Roundup: Singapore OKs VUNO’s AI fundus evaluation software program and extra briefs

Singapore clears VUNO’s AI software program for fundus evaluation

South Korean medical AI agency VUNO has not too long ago obtained a medical system certification from Singapore’s Well being Sciences Authority for its AI-based fundus evaluation software program.

The VUNO Med-Fundus AI analyses photographs of the fundus, which is the again a part of the attention, to supply findings vital for the prognosis of retinal ailments. It may well detect the placement of lesions indicative of ailments, similar to diabetic retinopathy, macular illness and glaucoma, inside seconds.

By way of this certification, VUNO can faucet into the rising medical gadgets market in Singapore, which is projected to succeed in $1 billion in worth in 2024, rising at an 8.7% CAGR from 2019.

---

Taiwan-based Level Robotics will get 510(okay) for its surgical robotic system

Level Robotics, maker of surgical robots in Taiwan, has obtained the US Meals and Drug Administration’s 510(okay) clearance for its built-in robotic-assisted surgical system for spinal fusion surgical procedures.

The POINT Kinguide Robotic-Assisted Surgical System combines image-guided navigation and a hand-held drilling characteristic to streamline procedural duties with precision, stability, and reproducibility of robotic movement. 

What units it other than related methods, in line with the corporate, is the parallel manipulator mechanism that permits it to develop indications for extra sophisticated herniated disc decompression surgical procedure.

Following the US clearance, Level Robotics is getting ready for CE marking in Europe and registration in China, increasing its presence in worldwide markets. 

“We goal to advertise availability and affordability of robotic’s adoption for spinal surgical procedure unaddressed by immediately’s expertise to deal with extra sufferers who contracted a spectrum of spinal ailments,” stated CEO SC Juang.

---

Psychological well being startup Lissun receives $1M in pre-seed funding

Indian psychological well being platform Lissun has raised $1 million in a pre-seed funding spherical led by IvyCap Ventures. The spherical was additionally participated by We Founder Circle, Supermorpheous and different marquee angel traders. 

The startup employs a singular “B2H2C” method – it reaches customers by way of its partnerships with healthcare establishments – in providing its full-stack psychological well being resolution. It has tie-ups with over 70 healthcare organisations in 17 cities in India.

Primarily based on a press assertion, Lissun’s expertise is utilized to high-stress use circumstances in six healthcare classes, similar to infertility, rehabilitation, nephrology, and oncology, amongst others. “The actual fact that psychological and emotional points could be an underlying downside in lots of medical circumstances is what we’ve got recognized and are engaged on proactively,” defined co-founder Dr Krishna Veer Singh.

By way of its contemporary funding, Lissun goals to strengthen its expertise’s spine and additional develop it to supply a seamless person expertise. Furthermore, it plans to develop to 25 cities, in addition to cowl 5 extra therapeutic classes.

---

India to repurpose COVID-19 apps

The Indian authorities plans to repurpose its two major cell functions for monitoring COVID-19 circumstances within the nation.

A information report cited Dr Ram Sewak Sharma, CEO of the Nationwide Well being Authority, as saying that they plan to reuse the contact tracing app Aarogya Setu as a nationwide well being app whereas the Covid Vaccine Clever Community (CoWIN) platform can be repurposed for the nationwide immunisation programme and a well being administration info system for small docs.